Clinical Trial Update: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) [Phase 1]

View source ↗

Summary

Phase 1 study of MK-7145 in participants with renal impairment and heart failure with renal impairment was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Impairment

Drugs mentioned

• MK-7145

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Renal Impairment, Heart Failure | Phase 1 | Status: TERMINATED | Results posted: 2017-03-03